There's a Silver Lining in Pfizer's Dark Cloud

There's a Silver Lining in Pfizer's Dark Cloud

Source: 
Motley Fool
snippet: 
  • Pfizer reported an adjusted loss of nearly $1 billion in the third quarter, and recently lowered its forecasts for coronavirus product sales.
  • The company also faces potential sales declines in other blockbusters as they lose exclusivity.
  • But Pfizer is progressing on a plan to boost growth.